You are here: Industry Insights > AskBio

News List

AskBio, Touchlight Restructure Former JV, Touchlight AAV contractpharma
February 08, 2022
Both parties benefit from co-exclusive rights to independently supply the Adeno-Associated Virus (AAV) market with doggybone DNA.
AskBio’s Gene Therapy Gets Fast Track contractpharma
July 22, 2021
LION-101 is a recombinant adeno-associated virus (rAAV) based vector being developed as a one-time treatment for Limb-Girdle Muscular Dystrophy.
AskBio’s Gene Therapy Program Gets Fast Track Designation contractpharma
June 29, 2021
LION-101 is a recombinant adeno-associated virus based vector being developed as a one-time intravenous infusion for Limb-Girdle Muscular Dystrophy Type 2I/R9.
AskBio, Selecta Biosciences Receive ODD for Methylmalonic Acidemia Treatment americanpharmaceuticalreview
December 04, 2020
Asklepios BioPharmaceutical and Selecta Biosciences announced the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to MMA-101, an AAV-based gene therapy in development for the treatment of isolated methylmalonic acidemia ...
Bayer acquires gene therapy specialist AskBio for $4bn pharmaceutical-technology
October 28, 2020
Bayer has announced the acquisition of US-headquartered cell and gene therapy specialist Asklepios BioPharmaceutical (AskBio) in a deal worth $4bn.
AskBio Acquires BrainVectis contractpharma
April 23, 2020
Expands clinical pipeline for neurodegenerative diseases with Huntington’s disease gene therapy candidate.
AskBio Appoints Chief Business Officer contractpharma
April 09, 2020
Asklepios BioPharmaceutical, Inc. (AskBio), a clinical-stage adeno-associated virus (AAV) gene therapy company, has appointed Don Haut, Ph.D., as Chief Business Officer to oversee business development strategy and execution.
AskBio Enters Research Collaboration with UNC contractpharma
March 19, 2020
Collaboration builds upon preclinical research that demonstrates potential for gene therapy to correct deficiency in UBE3A gene.
AskBio acquires Synpromics, expands gene therapy technology portfolio biospectrumasia
August 15, 2019
Synpromics to operate as a wholly owned subsidiary; the two companies bring together pioneering technology to increase efficacy of gene therapeutics
AskBio Acquires Synpromics Ltd. contractpharma
August 15, 2019
The two companies bring together pioneering technology to increase efficacy of gene therapeutics.

Previous page 1 2 Next page